Preconditioning and the human heart

S H Rezkalla1, R A Kloner

  • 1Department of Cardiology, Marshfield Clinic, Marshfield, WI 54449, USA. rezkalla.shereif@marshfieldclinic.org

Panminerva Medica
|October 8, 2005
PubMed

Insights

Ischemic preconditioning, brief heart ischemia, protects the heart during myocardial infarction and surgery. This cardioprotective effect may be mimicked by new drugs, offering future therapeutic potential.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Ischemic preconditioning involves brief episodes of ischemia that protect the heart against sustained ischemia.
  • This phenomenon is observed during acute myocardial infarction and coronary bypass surgery, leading to improved outcomes.

Purpose of the Study:

  • To review the protective effects of ischemic preconditioning in cardiac events.
  • To explore the clinical applications of ischemic preconditioning during coronary interventions and surgery.
  • To discuss the potential of preconditioning mimetic drugs.

Main Methods:

  • Review of existing literature on ischemic preconditioning.
  • Analysis of clinical outcomes associated with preconditioning in myocardial infarction and surgery.
  • Discussion of interventional techniques mimicking preconditioning.

Main Results:

  • Ischemic preconditioning is associated with smaller infarction size, reduced cardiac arrhythmias, and better left ventricular function.
  • Brief balloon inflations in cardiac catheterization can induce preconditioning effects.
  • Preconditioning reduces perioperative infarctions and arrhythmias during coronary bypass surgery.

Conclusions:

  • Ischemic preconditioning offers significant cardioprotection during myocardial infarction and surgery.
  • Clinical interventions can be employed to mimic preconditioning.
  • Pharmacological approaches using preconditioning mimetic drugs show promise for future cardiac protection.